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1. To determine whether there are differences in hippocampal volume (grey matter) in 
women who experience intimate partner violence versus those who do not. Does 
the presence of a psychiatric disorder, like PTSD, or substance abuse/dependency 
account for any differences? 
2. To determine whether there are any differences in the white matter tracts between 











                                                                                                                                           
Background 
 
Violence in its many forms is recognized as a worldwide problem.  At the domestic level, 
violence has a significant impact on the morbidity and mortality of women children and 
adolescents. 
 
Intimate partner violence (IPV) is a global public health problem. Population-based 
surveys from North America indicate that 1 in 4 women have ever experienced IPV, 1 in 
10 are current victims [1-2]. Similarly, a cross-sectional survey from South Africa found 
that the lifetime prevalence of women experiencing IPV was 24.6%, and 9.5% in the last 
year [3]. The high prevalence of adverse physical and mental health outcomes, related 
to IPV is well documented [4-6], and includes chronic pain, gastrointestinal, and 
gynaecological signs such as sexually- transmitted diseases, depression, posttraumatic 
stress disorder (PTSD), alcohol and drug abuse. IPV accounts for up to 2.9% of the total 
disease and injury burden for women of all ages [7]. For those aged 18-44 years this 
increased to 7.9%, with poor mental health and substance abuse contributing 73% and 
22%  of the total burden attributable to IPV, respectively [7]. 
 
In pregnancy, rates of IPV are noted to be between 3-13% [8]. In South Africa,  abuse 
during pregnancy is at least 6.8% [9]. Women who are pregnant and are exposed to  IPV 
have high rates of stress, are more likely to smoke or use other drugs, deliver a preterm 
or low birth weight infant, have an increase in infectious complications, and are less 
likely to obtain prenatal care [10-11]. Furthermore, exposure to violence as a child, 
whether by experiencing maltreatment or by witnessing IPV, is related to being in an 











likely to assault their intimate partners, and daughters of women who are beaten are 
more likely to be beaten as adults [13]. This suggests that a significant number of South 
African children are at risk of adverse outcomes. 
 
The deleterious and far reaching health and social consequences of IPV are complex 
and bound to multiple environmental and biological factors. Attempts to disentangle 
some of these links, requires an initial examination of the extent of the problem, and a 
review of known health related associations. 
 
Alcohol consumption is associated with increased risk of all forms of interpersonal 
violence [14-15]. In South Africa, intimate partner violence has been shown to be 
significantly positively associated with drinking alcohol [3]. Furthermore, alcohol abuse is 
a significant problem in South Africa, with one study reporting that 37.4% of men and 
10.7% of women were identified as hazardous drinkers [16]. Also of significance is the 
finding that 30-50 %  of arrestees in Cape Town, Durban, and Johannesburg charged 
with offences categorised as “family violence” have raised blood alcohol levels , 
increasing the weight of evidence linking alcohol and violence [17]. 
 
 Most of the research examining the health outcomes following IPV have come from 
industrialized countries, and show that depression and PTSD are the most prevalent 
mental health related sequelae [18-19], followed by alcohol and drug abuse [20-21]. 
Although it is difficult to establish causal pathways between alcohol abuse and IPV, one 
study postulated that the use of substances as an outcome of IPV was through PTSD 
[22]. They suggest that women might use alcohol to cope with specific groups of 
symptoms associated with PTSD, such as avoidance, hyperarousal and intrusion. 












More research is needed, particularly from developing countries, to elucidate the 
biological factors that mediate the cycle of alcohol use and violence against women. This 
may be used to identify vulnerable individuals, and or institute effective interventions. 
 
One possible avenue of research is to examine brain structure in women exposed to IPV. 
 
The hippocampal formation in the mesial temporal lobe is a sensitive and vulnerable 
brain region [23]. Several studies have shown that repeated stressful experiences [24] 
and elevated levels of glucocorticoids [25] can lead to hippocampal structural damage 
with neuronal loss. Several magnetic resonance imaging (MRI) studies have shown 
significantly smaller hippocampal volumes in patients with PTSD caused by different 
trauma, including personal violence [26]. Futhermore, meta-analyses of MRI volumetric 
studies showed that subjects with PTSD have smaller hippocampal volume than healthy 
and traumatized subjects without PTSD [27-29]. However, this has not been a consistent 
finding in all studies. In particular, Fennema-Notestine et al found that intimate partner 
violence subjects with posttraumatic stress disorder did not demonstrate significantly 
smaller hippocampal or other mesial temporal lobe volumes [30].  
 
In addition other structural changes have been found. Victims of intimate partner 
violence had smaller supratentorial cranial vaults and smaller frontal and occipital grey 
matter volumes relative to nonvictimized comparison subjects. Supratentorial cranial 
vault volume was negatively correlated with severity of childhood physical abuse, but not 
with intimate partner violence or posttraumatic stress disorder severity [30]. This study 












The hippocampus is more vulnerable than other brain structures to the neurotoxic effects 
of alcohol [31]. It is reported that patients with chronic alcoholism have decreased brain 
weights and volumes [32-33]. The hippocampal volume reductions in patients with 
chronic alcoholism have been found to be proportional to the reduction in total brain 
volume [31]. Thus alcohol consumption needs to be accounted for in studies examining 
hippocampal damage. 
 
Nevertheless, it would be important to include subjects who report alcohol use in a study 
investigating the biological correlates of IPV, since it is known that alcohol use is 
entangled in the cycle of violence, PTSD and other adverse health outcomes. 
 
In this study we would like to determine the relationship between IPV and the 
hippocampal volume, controlling for PTSD and substances. 
 
Much of the work on the psychobiology of PTSD has focused on grey matter measures. 
However, animal work suggests that white matter tracts are also important. Functional 
neuroimaging studies have shown decreased activity in the medial prefrontal and 
anterior cingulate areas to be correlated with increased activity of the amygdala 
[34].Therefore it has been suggested that PTSD represents a failure of medial prefrontal 
and anterior cingulate networks to regulate the activity of the amygdala, which results in 
hyper-reactivity to threat [35]. 
 
Diffusion tensor imaging (DTI) is a non-invasive MRI technique that enables the 
measurement of the diffusion of water in tissue in order to produce white matter tract 
images. Axonal membranes and myelin behave as major barriers to water diffusion, so 











averaged measure of diffusion, and a reduction of fractional anisotropy (FA), a measure 
of the directionality of diffusion, which varies from zero (diffusivity equal in all directions) 
to one (entirely unidirectional). This method is increasingly being used to measure in 
vivo integrity of white matter tracts. 
 
One of the first studies to use DTI using a voxel-based approach in subjects with PTSD, 
reported a significant increase in FA in the left anterior cingulum in subjects with PTSD 
compared to those without [36]. Another study by Kim MJ et al reported a significant 
reduction in FA in the left anterior cingulate in subjects with PTSD compared to those 
without [37]. This group went on to examine eight isocubic regions of interest (ROI) in 
the cingulum bundle, and found that relative to the comparison group , PTSD subjects 
had significantly smaller FA values in the left ROI’s but not in  the right side [38]. 
These studies recruited subjects with PTSD following a once off traumatic event. They 
excluded individuals with lifetime exposure to severe psychological trauma including 
violence. In relation to the South African context, our interest is in complex PTSD 
(exposure to chronic multiple trauma), and how violence against women, in all its forms, 
affects the brain. To our knowledge, there has been no DTI study of subjects with 






















Participants for our case control study will be recruited from an ongoing MRC funded  
randomized clinical trial in Ceres , “ The prevention of Fetal Alcohol Spectrum Disorder 
through a brief intervention with pregnant women “ – PI Sandra Marais , that recruits 
pregnant women who are abusing alcohol. 
 
In this trial all women (15 years and older) attending prenatal ultrasound scans at the 
Ceres Hospital were screened for alcohol consumption.   
The group of women who indicated that they used alcohol were then screened further 
(visit 1), using the Alcohol Use Disorders Identification Test (AUDIT) to distinguish the 
“low-risk and risky” drinkers (< 7drinks a week, < 5 drinks per occasion) the “hazardous” 
drinkers (> 7 drinks per week, > 5 drinks per occasion) and those who are “alcohol 
dependent”.  Women who tested positive for risky and hazardous drinking were 
randomly allocated to an intervention and a control group according to cluster, 
randomized sampling. Women who were found to be alcohol dependent were 
appropriately referred for treatment.  
An Abuse Assessment Screen (AAS) was completed   in both control and intervention 
samples (visit 4 , day 58). 
 
In our study we will recruit 40 women from the main study after they have delivered.  
These women will be re-interviewed using the following tools: Abuse Assessment 
Screen (AAS), Alcohol Use Disorders Identification Test (AUDIT) and the Mini 
International Neuropsychiatric Interview (MINI). 











Controls are defined as women with no reports of violence in the previous year. 




Age 15- 65 years of age 
 
Exclusion criteria 
1. Previous head injury 
2. Other neurological conditions such as epilepsy and cerebrovascular disease 
3. Severe current medical illness  
4. Investigators clinical judgment 







Demographic data will be obtained for all  participants .  
 
 Alcohol Use Disorders Identification Test (AUDIT) 
 
The AUDIT is a 10 item test developed by the World Health Organization to determine 
whether a person’s use of alcohol is harmful. It is validated for use in both developed 











alcohol dependence and 7-10 consider alcohol related problems. The maximum total 
score is 40. A score of 4 or more out of 12 for questions 4-16 suggests alcohol 
dependence. In women a score of 7 or more indicates a strong likelihood of hazardous 
or harmful alcohol consumption. A score of 13 or more is suggestive of alcohol related 
harm.  
 
Abuse Assessment Screen (AAS) 
 
This screening tool devised in the 1990’s, assesses physical abuse against pregnant 
women.  Besides a question tapping sexual coercion, the abuse assessment screen 
(AAS) consists of three anchor questions related to the abuse perpetrated by the partner 
or someone important to the respondent. These are inclusive, respectively covering 
lifetime, preceding 12 months, and pregnancy periods. The opening question 
simultaneously deals with emotional and physical violence. The last two are restricted to 
physical abuse, inquiring at once whether the women has been hit, slapped, kicked, or 
otherwise physically hurt. Provided the answer is positive, details about the perpetrator 
and characteristics of the event are further checked. It is valid and reliable test in both 
clinical and community settings. 
 
Mini International Neuropsychiatric Interview (MINI) 
This is a short structured diagnostic interview, developed jointly by psychiatrists and 
clinicians in the United States and Europe, for DSM-IV and ICD-10 psychiatric disorders. 
With an administration time of approximately 15 minutes, it was designed to meet the 
need for a short but accurate structured psychiatric interview. This is a valid and reliable 













The Cape Universities Brain Imaging Centre (CUBIC) is a collaborative research 
initiative between Siemens, Stellenbosch University, the University of Cape Town, and 
the Medical Research Council.  We will have access to Africa's first 3 Tesla Siemens 
Allegra MRI scanner to perform MRI and DTI scans for each participant. Scans will be 
taken at least 5 months post delivery to allow for any pregnancy related changes to 





The field worker will visit the women from the main study and obtain written consent from 
40 candidates. Transport will be provided to and from CUBIC. During the visit to CUBIC, 
the women will undergo a psychiatric interview, an MRI scan that will include DTI 
sequences.  
 
For the MRI data, the region of interest is the hippocampus. 3D T1-weighted MPRAGE 
(9 minutes) and 3D T2-weighted (9 minutes) sequences will be taken. The sequences 





Data analysis will be performed using the SPSS statistical package in collaboration with 












Participants will be divided into groups. 
Cases: defined as women who report IPV in the last year (a score of > 1 on the AAS)  
Controls:  defined as women with no reports of violence in the previous year. 
 
Cases and controls will be compared on demographic variables (eg age, parity, highest 
level of education, employment) using ANOVA and Chi square as appropriate. 
 
Hippocampal volume measurements 
The FSL software package FIRST (FMRIB’s integrated registration and segmentation 
tool) will be used to determine volume and shape differences for the left and right 
hippocampus (Patenaude et al. 2007). The process is as follows: the T1 images of each 
subject are transformed to MNI152 space by a 12-degree affine transformation. After the 
subcortical structures are aligned, a subcortical mask is applied to locate the different 
subcortical regions. Segmentation of these regions is then performed according to 
standardized shape models and voxel intensities. The absolute volumes of the individual 
structures are calculated, taking into account the transformation parameters of the initial 
registration. For this specific study, a boundary correction will be applied to the 
hippocampus to determine which voxels along the boundary belong to the structure. A 
correction with a z-value of 3 will be used in this regard. The segmentations and 
registrations will be examined for any misregistration A vertex statistical analysis will 
then performed on the segmented hippocampus for each subject to examine whether 
there are any significant differences in hippocampus structure and shape between cases 
and controls.  
 












The whole analysis will be performed in the FMRIB’s software library (FSL) (Smith 2006). 
For the data analysis, fractional anisotropy (FA) and mean diffusion (MD) maps will be 
created by firstly doing brain extraction (BET) and then fitting a tensor model to the raw 
diffusion data using FMRIB’s Diffusion Toolbox (FDT) (Smith 2002). The subjects FA 
data will be aligned into a common space using the non-linear registration tool FNIRT 
(Andersson 2007). The mean FA image will then be created and thinned to create a 
mean FA skeleton that represents the centres of all WM tracts common to the group. 
Each subject’s aligned FA data will then projected onto the skeleton and resulting data 
fed into voxelwise cross-subject statistics. For the MD images, the original non-linear 
registration parameters will be applied and all the subjects’ MD data will be projected 
onto the mean FA skeleton, using the FA data to find the projection vectors. The 
statistical model will be a two-tailed unpaired t-test with threshold-free cluster 
enhancement for the two groups. Only clusters that have a p-value <0.05 corrected for 




The aims of the study will be explained to each participant before written consent is 
signed. 
MRI is a safe scanning technique with no known harmful effects to women post delivery 
All information received from participants will be kept as confidential and will not form 
part of their routine clinical records. 
Participants who are identified as having a psychiatric disorder, including suicidality, will 












The study will be conducted according to the ethical guidelines and principles of the 
international Declaration of Helsinki, South African Guidelines for Good Clinical Practice 
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PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
 
A comparative study of  hippocampal volume and posttraumatic stress disorder  in 
women who report alcohol use and intimate partner violence (IPV) versus those without 





PRINCIPAL INVESTIGATOR: Dr Bavanisha Vythilingum 
 
ADDRESS: Department of Psychiatry and Mental Health , Groote Schuur Hospital 
, Observatory , 7925 
 
CONTACT NUMBER: (021 ) 404 2137 
 
You are being invited to take part in a research project.  Please take some time to read 
the information presented here, which will explain the details of this project.  Please ask 
the study staff or doctor any questions about any part of this project that you do not fully 
understand.  It is very important that you are fully satisfied that you clearly understand 
what this research entails and how you could be involved.  Also, your participation is 
entirely voluntary and you are free to decline to participate.  If you say no, this will not 
affect you negatively in any way whatsoever.  You are also free to withdraw from the 
study at any point, even if you do agree to take part. 
 
This study has been approved by the Committee for Human Research at Cape Town 
University and will be conducted according to the ethical guidelines and principles of 
the international Declaration of Helsinki, South African Guidelines for Good Clinical 
Practice and the Medical Research Council (MRC) Ethical Guidelines for Research. 
 
 
What is this research study all about? 
We are interested in learning more about the  effects that  alcohol use and violence in 
women, have on the brain. We know that alcohol and violence are linked and 
associated with a number of mental health problems , such as posttraumatic stress 
disorder (PTSD). We will use a brain scan (magnetic resonance imaging MRI) to study 
a region of the brain that is sensitive to stress and alcohol. A questionnaire on PTSD ( 
called the Harvard Trauma Questionnaire HTQ) will help us to identify women who may 
suffer from this. 
We will study 60 women from the Ceres area who have taken part in the Prevention of 
Fetal Alcohol Spectrum Disorder through brief interventions for pregnant women.  
 We will compare the results from the  brain scans and HTQ’s. 
 
 
Why have you been invited to participate? 
In the above mentioned study that you have participated in , you indicated whether you 
used alcohol and whether you experienced any abuse at home. To determine whether 
there are any brain differences between groups of women  who use alcohol and 
















What will your responsibilities be? 
You will be required to make a single  visit to  CUBBI , Stellenbosch University.  A 
mental health professional will help you to complete a questionnaire asking about PTSD 
During this same visit you will be required to have a brain scan (MRI). 
 
 
Will you benefit from taking part in this research? 
Appropriate treatment will be offered if you are found to have PTSD.  
There may not be any immediate personal benefit to you for taking part , however , a 
better understanding of why some women who drink alcohol are exposed to violence at 
home while others who drink avoid this risk , may help us to develop appropriate 




Are there any risks involved in your taking part in this research? 
Magnetic Resonance Imaging (MRI) is a safe procedure , provided you do not have any 
of the following : pacemaker , aneurysm clip , artificial valve, vena cava filter, prosthesis 
(eye, breast etc), cochlear implants, shrapnel in eye or body , neurostimulator, any other 
implants like screws, plates , rods or joint replacements. 
Brain images are captured using powerful magnetic fields. Ionising radiation is not used. 
There are no harmful effects .  




If you do not agree to take part, what alternatives do you have? 
You can continue to access medical care from your local clinic and hospital. 
 
 
Who will have access to your medical records? 
The information collected will be treated as confidential and protected. The identity of 
each participant remains anonymous in the event the study is published. The 
researchers have access to the information only. 
. 
 
Will you be paid to take part in this study and are there any costs involved? 
 
No you will not be paid to take part in the study but your transport and meal costs will be 
covered for each study visit.  There will be no costs involved for you, if you do take part. 
 
 
Is there any thing else that you should know or do? 
You can contact Dr Flegar at (021) 4042137 if you have any further queries or 
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You can contact the Committee for Human Research at 021-4066492 if you have any 
concerns or complaints that have not been adequately addressed by your study doctor. 
You will receive a copy of this information and consent form for your own records. 
 
 
Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled (insert title of study). 
 
I declare that: 
 
∑ I have read or had read to me this information and consent form and it is 
written in a language with which I am fluent and comfortable. 
∑ I have had a chance to ask questions and all my questions have been 
adequately answered. 
∑ I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
∑ I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
∑ I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, 
as agreed to. 
 
 




 .................................................................   ............................................................... 
Signature of participant Signature of witness 
 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
∑ I explained the information in this document to ………………………………….. 
∑ I encouraged him/her to ask questions and took adequate time to answer 
them. 
∑ I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
∑ I did/did not use a interpreter.  (If a interpreter is used then the interpreter 
must sign the declaration below. 
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 .................................................................   ............................................................... 
Signature of investigator Signature of witness 
 
 
Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
∑ I assisted the investigator (name) ………………………………………. to 
explain the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
∑ We encouraged him/her to ask questions and took adequate time to answer 
them. 
∑ I conveyed a factually correct version of what was related to me. 
∑ I am satisfied that the participant fully understands the content of this 








 .................................................................   ............................................................... 











ABUSE ASSESSMENT SCREEN 
 
1. Have you ever been emotionally or physically abused by your partner or someone important to you? 
(i) Yes                                                                 (ii) No 
 
2. Within the last year, have you been hit, slapped, kicked or otherwise physically hurt by someone? 
(i) Yes                                                                 (ii) No 





(e) Others (specify)__________   Number of times: _______ 
 
3. Since you have been pregnant, have you been hit, slapped, kicked or otherwise physically hurt by 
someone? 
 
(i) Yes                                                                 (ii) No 





(e) Others (specify) 
Number of times: _______   Indicate the area of injury:____________________________ 
Score the most severe incident to the following scale: 
1. Threats of abuse, including use of a weapon 
2. Slapping, pushing; no injuries and/or lasting pain 
3. Punching, kicking, bruises, cuts and/or continuing pain 
4. Beaten up, severe contusions, burns, broken bones 
5. Head, internal, and/or permanent injury 
6. Use of weapon, wound from weapon 
 
4. Within the past year, has anyone forced you to have sexual activities? 
(i) Yes                                                                  (ii) No 





(e) Others (specify)    Number of times: _______ 
 
5. Are you afraid of your partner or anyone you listed above? 
(i) Yes                                                                  (ii) No 
 
6. Do you want us to reveal this information to: (for those who answered yes to questions 2,3, or 4) 
(a) The obstetricians looking after you 
     (i) Yes                                                      (ii) No 
(b) The medical social worker for further management 














NAAM:  ________________________________________Verw. No: ____________ 
ADRES: ________________________________________Datum: ______________        
                                                                                                Tel. No:______________ 
Inligting van Kliniek Rekord Kaart 
                                                Verbruiker                       Staker                                    Nie-verbruiker 
Tabak    
Alkohol    
Dwelms/ander middels    
SCREENING FOR ALCOHOL USE (THE AUDIT)  (Onderhoud  weergawe)   
Lees die vrae soos dit geskryf is.  Skryf antwoorde versigtig neer.  Begin die AUDIT deur te sê, 
“Ek gaan u nou vrae vra oor u alkohol gebruik die afgelope jaar ”.  Verduidelik wat ‘n 
“standaard drankie” is en hoe om dit te bepaal.  Kodeer die antwoorde volgens die “standaard 
drankie ”.  Plaas die korrekte nommer vir die antwoord bo die strepie. 
1.  Hoe gereeld drink u alkohol? 
(0)   Nooit (gaan na 9-10) 
(1)   Maandeliks of minder   
(2)   2-4 keer per maand 
(3)   2-3-keer per week 
(4)   4 keer en meer per week                                   ________ 
  
6.  Hoe gereeld oor die afgelope jaar was dit vir u nodig om 
‘n regmaker in die oggend te drink ná ‘n hewige 
drinksessie? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3)   Weekliks 
(4)   Daagliks of byna daagliks                                 ________ 
 
2.  Hoeveel drankies met alkohol drink u gewoonlik op ‘n 
keer? 
(0)   1 of 2 
(1)   3 of 4 
(2)   5 of 6 
(3)   7,8, of 9 
(4)   10 of meer                                                             _______                                                         
                                                                                                              
7.  Hoeveel keer die afgelope jaar het u skuldig en spyt 
gevoel nadat u gedrink het? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3)   Weekliks 
(4)   Daagliks of amper daagliks                              ________ 
 
3.  Hoe dikwels drink u meer as ses drankies op ‘n keer? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3)   Weekliks 
(4)  Daagliks of amper daagliks                                 _______                        
                      
4.  Hoe gereeld die afgelope jaar het u ondervind dat as u 
begin drink kan u nie ophou nie? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3)   Weekliks 
(4)   Daagliks of byna daagliks                               _________ 
                                                             
8.  Hoeveel keer die afgelope jaar kon u nie onthou wat die 
vorige aand gebeur het nie omdat u alkohol gedrink het? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3) Weekliks 
(4)   Daagliks of amper daagliks                            _________ 
 
9.  Het u of iemand anders al seergekry as gevolg van u 
alkohol gebruik? 
(0)   Nee 
(1)   Ja, maar nie die afgelope jaar nie? 
(2)   Ja, die afgelope jaar            
                 
                                                                                       _______ 
                     
5.  Hoe gereeld die afgelope jaar het u u pligte versuim as 
gevolg van u drank gebruik? 
(0)   Nooit 
(1)   Minder as maandeliks 
(2)   Maandeliks 
(3)   Weekliks 
(4)   Daagliks of byna daagliks                                 ________ 
                                                   
10.  Was ‘n familielid, dokter, vriend of ander 
gesondheidswerker al bekommerd oor u alkohol gebruik 
en het hulle al voorgestel dat u minder drink? 
(0)   Nee 
(1)   Ja, maar nie die afgelope jaar nie 
(2)   Ja, die afgelope jaar                                         _________ 
                                                               
 
AUDIT ZONE LEVEL: _____________________________ 
SKRYF TOTAAL VAN ITEMS 1-10 HIER 
                                                                     ________________ 
11.   Dink u dat u nou ‘n probleem het met alkohol 
gebruik? 
              (a)   Nee 
              (b)   Moontlik nie 
              (c)   Onseker 
              (d)   Moontlik      
              (e)   Definitief            
      
Ruler scale for  readiness:        a___b___c___d___e 
Motivation 
12.  Hoe moeilik sal dit vir u wees om oor die volgende 
paar maande minder alkohol te gebruik of om op te hou 
drink? 
         (a)   Baie maklik 
         (b)   Redelik maklik 
         (c)    Nie moeilik of maklik nie 
         (d)   Redelik moeilik 
         (e)    Baie moeilik 
Ruler scale for Readiness:           a___b___c___d___e  
Confidence 
Moenie vrae 11 en 12 saam tel nie.  Hierdie vrae gee ‘n aanduiding van die kliënt se gereedheid of motivering om sy 
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Alle regte word voorbehou. Geen gedeelte van hierdie dokument mag gereproduseer of versend word 
in enige vorm, of op enige manier, elektronies of meganies, ingeslote fotokopieering, of deur enige 
inligting herwinningsisteem, sonder skriftelike toestemming van die outeure. Navorsers en klinici wie 
in nie-winsgewende of publieke opsette werksaam is (ingeslote universiteite, non-privaat hospitale en 












M.I.N.I. 5.0.0 Afrikaan version / DSM-IV / current (August 1998) 
 
NAAM VAN PASIENT:  _____________________ PROTOKOL NOMMER::  _____________________ 
GEBOORTE DATUM:  _____________________ TYD ONDERHOUD BEGIN:  _____________________ 
ONDERHOUDVOERDER : _____________________ TYD ONDERHOUD VOLTOOI::  _____________________ 





MODULES TYDSPAN  
A. MAJOR DEPRESSIEWE  EPISODE HUIDIG (Laaste 2 weke) + 
Lewenslank 
 
A’. MDE MET MELANCHOLIE Huidig (afgelope 2 weke) Opsioneel 
B. DISTIMIE Huidig (afgelope 2 jaar)  
C. SELFMOORDRISIKO Huidig (afgelope maand)  
D. (HIPO) MANIESE EPISODE Huidig+ Lewenslank  
E. PANIEKSTEURING Lewenslank + huidig 
(afgelope maand) 
 
F. AGORAFOBIE Huidig  
G. SOSIALE FOBIE Huidig (afgelope maand)  
H. OBSESSIEF-KOMPULSIEWE 
STEURING 
Huidig (afgelope maand)  
I. POST TRAUMATIESE 
STRESSTEURING 
Huidig (afgelope maand) Opsioneel 
J. ALKOHOL AFHANKLIKHEID / 
MISBRUIK 




MISBRUIK (Nie alkohol) 
Huidig  (afgelope 12 
maande) 
 
L. PSIGOTIESE STEURINGS Lewenslank + Huidig  
M. ANOREKSIA NERVOSA Huidig  (afgelope 3 maande)  
N. BULIMIA NERVOSA Huidig (afgelope 3 maande)  
O. ALGEMENE ANGSSTEURING Huidig (afgelope 3 maande)  



















Die M.I.N.I. is ontwerp as ‘n kort gestruktureerde onderhoud vir die primêre As I psigiatriese steurings in DSM-IV en 
ICD-10. Geldigheid- en betroubaarheidstudies is gedoen om die M.I.N.I. met die SCID-P en die CIDI te vergelyk. Die 
resultate van hierdie studies toon dat die M.I.N.I. aanvaarbare geldigheid- en betroubaarheidstellings het, maar kan in 
‘n baie korter tyd  (gem. 18.7 ± 11.6 min., mediaan 15 min.) geadministreer word as bogenoemde instrumente. Dit kan 
na ‘n kort opleidingsessie deur klinici gebruik word. Ander onderhoudvoerders het meer intensiewe opleiding nodig. 
 
• Onderhoud: 
Om die onderhoud so kort as moontlik te hou, moet die pasient ingelig word dat u ‘n onderhoud gaan voer wat meer 
gestruktureerd as normaalweg is, met spesifieke vrae oor sielkundige probleme wat ‘n «ja» of «nee» antwoord 
verg.  
 
• Algemene formaat : 
Die M.I.N.I. word onderverdeel in  modules wat deur  letters geidentifiseer word en wat elk ooreenstem met ‘n 
diagnostiese kategorie. 
• Aan die begin van elke module (behalwe die module vir psigotiese toestande ),  is daar siftingvrae wat 
ooreenstem met die hoof kriteria van die siekte. Die kriteria word aangebied in ‘n grys area. 
• Aan die einde van elke module is daar diagnostiese areas, wat die klinikus in staat stel om aan te dui of daar 
aan die diagnostiese kriteria voldoen word. 
 
• Algemeen: 
Sinne wat in  « gewone druk » geskryf is, moet presies só gelees word, om die raming van die diagnostiese kriteria 
te standariseer. 
Sinne wat in  « HOOFLETTERS » geskryf is moet nie aan die pasient gelees word nie. Dit is instruksies aan die 
onderhoudvoerder om te help met die telling van die diagnostiese algoritmes. 
Sinne wat in  «  bold » geskryf is dui die tydstrek van die ondersoek aan. Die onderhoudvoerder moet dit so gereeld 
as wat dit nodig is lees. Slegs simptome wat voorkom gedurende die tydgleuf wat aangedui word moet oorweeg 
word wanneer die respons  bereken word. 
Sinne (in parenteses/hakies) is kliniese voorbeelde van die simptome. Hierdie mag aan die pasient voorgelees word 
om die vraag te verklaar. 
Antwoorde met ‘n peiltjie bo ( Ë ) dui aan dat daar nie voldoen word aan een van die kriteria wat nodig is vir die 
diagnose nie. In so ‘n geval, moet die onderhoudvoerder na die einde van die module gaan om  « NEE » te omkring 
in al die diagnostiese boxes en daarna na die volgende module  beweeg. 
Wanneer terme met ‘n slash (/) geskei word moet die onderhoudvoerder slegs die simptome lees wat bekend is om 
teenwoordig te wees by die pasient (byvoorbeeld, vraag A3). 
 
• Evaluerings Instruksies: 
Alle vrae wat gelees word moet evalueer word. Die evaluering word gedoen teen die regte kant van elke vraag deur 
of JA of NEE te omkring. Die klinikus moet seker wees dat elke dimensie van die vraag in ag geneem word deur 
die pasient (bv.: tydsduur, frekwensie, ernstigheid, « en/of » alternatiewe). 
 
Simptome wat beter voor verklaar kan word  deur ‘n organiese  oorsaak of deur die gebruik van alkohol of 
substanse moet nie positief  gekodeer word in die M.I.N.I. nie. Die M.I.N.I. Plus het vrae wat hierdie kwessies 
ondersoek. 
 
Vir enige vrae, voorstelle, behoefte aan ‘n opleiding sessie, of inligting i.v.m. die hersiening van die M.I.N.I., 
kontak asb.: 
 
David SHEEHAN, M.D., M.B.A. 
University of South Florida 
Institute for Research in Psychiatry 
3515 East Fletcher Avenue  
Tampa , FL USA 33613-4788 
tel : +1 813 974 4544 
fax : +1 813 974 4575 
e-mail : dsheehan@com1.med.usf.edu 
Yves LECRUBIER, M.D. / Thierry HERGUETA, M.A. 
INSERM U302 
Hôpital de la Salpétrière 
47, boulevard de l’Hôpital 
F. 75651 PARIS – FRANCE 
tel : +33 (0) 1 42 16 16 59 
fax : +33 (0) 1 45 85 28 00 
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Was u aanhoudend depressief of mismoedig vir die grootste gedeelte van die 















Was u in die laaste twee weke minder geinterreseerd in die meeste dinge of 



















A3 Wanneer u depressief of ongeinterreseerd in die laaaste twee weke 
gevoel het: 
 
    
 a Het u eetlus afgeneem of toegeneem bykans elke dag of het u gewig 
toegeneem of afgeneem sonder dat u probeer het? (m.a.w., ± 5 % van 
liggaamsgewig of ± 3,5 kg of ± 8 lbs., vir ‘n 70 kg / 120 lbs. persoon in ‘n 
maand)  













Het u omtrent elke aand probleme ondervind om te slaap (raak u moeilik aan 
die slaap, word u in die middel van die nag wakker, word u vroeg wakker of 
















Het u omtrent elke dag stadiger beweeg of gepraat as normaalweg? Was u 












































Het u  herhaardelik oorweeg om uself te beseer, selfmoordgedagtes 














IS 3 OF MEER A3 ANTWOORDE JA ? 




 NEE JA 










INDIEN DIE PASIENT HUIDIG AAN DIE KRITERIA VIR ‘N MAJOR DEPRESSIEWE 
EPISODE VOLDOEN  : 
 
Het u ooit gedurende u leeftyd periodes gehad waar u vir twee weke of meer 
depressief gevoel het, of ongeinterreseerd was in die meeste dinge en waar u 
meeste van die probleme gehad het waarvan ons nou gepraat het ? 
 
Was daar ‘n tydperk van ten minste 2 maande sonder depressie en/of ‘n 

































IS A5b gekodeer JA? 
 
 
 NEE JA 
MAJOR DEPRESSIEWE 
EPISODE VERLEDE  
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A’. MAJOR DEPRESSIEWE EPISODE MET MELANCHOLIESE EIENSKAPPE  (opsioneel) 













 b Gedurende die ergste tydperk van die huidige episode , het u ooit u vermoe 
verloor om te reageer op dinge wat voorheen vir u plesier verskaf het of wat 
u opgebeur het? 
INDIEN NEE: Wanneer iets goed gebeur, het dit u nooit laat beter voel nie, 




















 Gedurende die laaste twee week periode, wanneer u depressief of 
ongeinterriseerd gevoel het: 
 
    
A7a Het u depressief gevoel op ‘n manier wat anders was as wanneer iemand na 









 b Het u gereeld erger in die oggend gevoel, omtrent elke dag ?  NEE JA 
 
15 
 c Het u omtrent elke dag ten minste 2 ure voor u gewone tyd wakker geword 








 e IS A3c JA ?  NEE JA 
 
17 
 d IS A3a JA (ANOREKSIE OF GEWIGSVERLIES ALLEEN )?  NEE JA 
 
18 
 f Het u oormatig skuldig gevoel of dat dit buite verhouding met die realiteit 









    
  
IS 3 OF MEER A7 ANTWOORDE JA? 
   




Met Melankoliese Einskappe 
HUIDIGLIK 
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B. DISTIMIE 
 
INDIEN DIE PASIENT SE SIMPTOME HUIDIG AAN  DIE KRITERIA VIR ‘N  MAJOR DEPRESSIEWE EPISODE VOLDOEN, MOENIE 





Het u vir die laaste twee jaar die meeste van die tyd hartseer, laag of 











Is hierdie tydperk onderbreek deur ‘n periode van twee maande of meer  










Gedurende hierdie tydperk toe u die meeste van die tyd depressief was : 














Het u probleme met u slaappatroon ondervind, in die sin dat u te veel of te 































































Het die simptome van depressie ‘n beduidende ongemak by u veroorsaak of 
u vermoe om by die werk, sosiaal of in ander belangrike maniere te 
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Het u in die laaste maand : 
























































In u leeftyd 
 















     
  
IS  TEN MINSTE 1 VAN BG. JA? 
 
INDIEN JA, DUI DIE VLAK VAN SELFMOORDRISIKO SOOS VOLG AAN : 
 
 C1 of C2 of C6 = JA : LAAG 
 C3 of (C2 +C6) = JA : GEMIDDELD 
 C4 of C5 of (C3 + C6) = JA : HOOG 
 
 
   





 LAAG ÿ 
 GEMIDDELD ÿ 
 HOOG ÿ 
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Het u al ooit ‘n tydperk beleef waar u so goed of «hoog»  of so vol energie 
of vol van uself gevoel het dat  u in die moeilikheid beland het, of dat ander 
persone gedink het u is nie uself nie? (Moenie tye wat u geintoksikeerd van 
alkohol of ander substanse was insluit nie.) 
INDIEN DIE PASIENT NIE DUIDELIKHEID HET OOR WAT BEDOEL WORD MET «HOOG» 
NIE, VERDUIDELIK DEUR TE SÊ :  Met «hoog» bedoel ek : u gemoed is gelig, u energie 
is verhoog, u benodig minder slaap, u gedagtes is vinniger, u is vol idees, u 
produktiwiteit, kreatiwiteit, motivering of impulsiewe gedrag is verhoog. 
 
















 b Voel u tans "hoog" of vol energie ? 
 
 NEE JA 2 
D2a Was u al ooit so aanhoudend geirriteerd, vir ‘n aantal dae, dat u argumente 
of verbale of fisiese gevegte gehad het of dat u op mense buite u familie 
geskree het? Het u, of ander, opgelet dat u meer geirriteerd is of oorreageer, 
in vergelyking met ander, selfs in omstandighede wat u voel dit was 
geregverdig? (Moenie tye wat u geintoksikeerd was met alkohol of ander 
substanse inagneem nie.) 
 



















 b Voel u tans gedurig geirriteerd? 
 
















INDIEN D1B OF D2B = JA : ONDERSOEK SLEGS HUIDIGE EPISODE 
INDIEN D1B EN D2B = NEE : ONDERSOEK SLEGS DIE MEES SIMPTOMATIESE 
EPISODE 
 
Gedurende die tye wat u «hoog», vol energie of geirriteerd gevoel het, 
het/was u: 
 




Gevoel dat u dinge kon doen wat ander nie kan doen nie, of dat u ‘n 
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So graag aan plesierige aktiwiteite (b.v. te veel geld uitgee, roekelose 

















IS 3 OF MEER D3 ANTWOORDE JA  











Het hierdie simptome ten minste ‘n week geduur en het dit beduidende 
probleme by die huis, werk of skool veroorsaak of was u gehospitaliseer vir 
die probleme? 
















     
  





INDIEN JA, SPESIFISEER OF DIE EPISODE HUIDIG OF IN DIE 
VERLEDE IS. 
 
   




 HUIDIG  
 VERLEDE  
 
    
  





INDIEN JA, SPESIFISEER OF DIE EPISODE HUIDIG OF IN DIE 
VERLEDE IS. 
 
   




 HUIDIG  
 VERLEDE  
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Het u, meer as een maal, vlae of aanvalle gehad waar u  skielik angstig, bang 
of ongemaklik gevoel het, self in omstandighede waar die meeste ander 
persone nie so sou voel nie? Het die aanval binne 10 minute sy piek bereik? 





















INDIEN E1 = NEE, OMKRING NEE IN E5 EN GAAN NA  F1 
Op enige tydstip in die verlede, het enige van hierdie aanvalle onverwags of 
spontaan voorgekom of in ‘n onvoorspelbare of  onuitgelokte manier? 













Het u al ooit so ‘n episode gehad wat gevolg is deur ‘n maand of meer se 
aanhoudende vrees vir nog ‘n aanval of bekommernis oor die gevolg van so 
‘n aanval? 
















Gedurende die ergste aanval wat u kan onthou : 
    
 a Het u hart ‘n slag gemis, vinniger of in u keel geklop ?  NEE JA 4 
 b Was u hande klam of sweterig ?  NEE JA 5 
 c Was u bewerig ?  NEE JA 6 
 d Was u kortasem of het u dit moeilik gevind om asem te haal?  NEE JA 7 
 e Het u ‘n versmorende gevoel of ‘n knop in u keel gehad?  NEE JA 8 
 f Het u  borskas pyn, drukking of ongemak gehad?  NEE JA 9 
 g Het u skielik naarheid, maagprobleme of diarree ervaar?  NEE JA 10 
 h Het u duiselig, lighoofdig, flou of onvas gevoel ?  NEE JA 11 
 i Het dinge om u vreemd, onwerklik, verwyderd of onbekend gevoel, of het u 







 j Het u gevoel dat beheer verloor of was u bang dat u besig is mal te word?  NEE JA 13 
 k Was u bang dat u besig is om te sterf?  NEE JA 14 
 l Was dele van u liggaam gevoelloos of prikkelend?  NEE JA 15 










 INDIEN E5 = NEE,  GAAN NA  E7   Panieksteuring  Lewnslank 
E6 In die laaste maand, het u sulke aanvalle herhaaldelik gehad (2 of meer) 
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Voel u gespanne of besonders angstig of ongemaklik in sekere plekke of 
situasies waar dit moeilik sal wees om te ontsnap, en waar hulp miskien nie 
beskikbaar sal wees in geval van ‘n paniek aanval nie, soos tussen ‘n groot 
groep mense, om in ‘n tou te staan, wanneer u alleen tuis is of wanneer u 
alleen weg is van die huis, of wanneer u ‘n brug oorsteek, reis in ‘n  bus, 

























INDIEN F1 = NEE,  OMKRING NEE BY  F2 





Is u so bang vir hierdie situasasies dat u dit vermy,  daardeur worstel, of dat 

















IS F2 (HUIDIG AGORAFOBIE)  GEKOODEER NEE 
en 
IS E6 (HUIDIG  PANIEKSTEURING) GEKODEER JA ? 
 
   
 NEE JA 
 
PANIEKSTEURING 
Sonder  Agorafobie HUIDIG 
 




IS F2 (HUIDIG AGORAFOBIE) GEKODEER JA 
en 
IS E6 (HUIDIG PANIEKSTEURING) GEKODEER JA ? 
 
   










IS F2 (HUIDIG AGORAFOBIE) GEKODEER JA 
And 
IS E5 (PANIEKSTEURING LEWENSLANK) GEKODEER NEE ? 
 
   
 NEE JA 
 
AGORAFOBIE  
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Was u in die laaste maand bang of skaam om dopgehou te word, om die 
middelpunt van die geselskap te wees, of om verneder te word ? Dit sluit 
situasies in soos om in die publiek te praat of te eet, te skryf terwyl iemand 




















































Ontwrig hierdie vrees u normale werk of sosiale funksionering of veroorsaak 













    
  
IS G4 GEKODEER JA ? 
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In die laaste maand, was u gepla deur herhalende gedagtes, impulse of 
beelde wat ongevraagd, onsmaaklik, ontoepaslik, indringend of ontstellend 
was ? (b.v. die gedagte dat u vuil is, gekontamineer is of kieme het of die 
vrees dat u ander kan kontamineer, of ‘n vrees om iemand skade aan te doen 
selfs al wou u  nie , of ‘n vrees dat u op ‘n impuls sal reageer, of ‘n vrees of 
bygeloof dat u verantwoordelik sal wees vir dinge wat verkeerd gaan, of 
obsessies met seksuele gedagtes, beelde of impulse, of ophoop, versameling, 
of godsdienstige obsessies.) 
 
MOENIE OORMATIGE BEKOMMERNIS OOR WERKLIKE LEWENSPROBLEME INSLUIT NIE.  
MOENIE OBSESSIES WAT DIREK VERBAND HOU MET EETSTEURINGS, SEKSUELE 
AFWYKINGS, PATOLOGIESE DOBBELARY, OF ALKOHOL OF MIDDEL MISBRUIK INSLUIT 
NIE, WANT DIE PASIËNT KAN PLESIER PUT UIT DIE AKTIWITEIT EN MAG DIT SLEGS 




































Het dit aanhou opkom in u gedagtes al het u probeer om dit te ignoreer of 
om daarvan ontslae te raak ? 
 














Glo u dat hierdie obsessies ‘n produk van u eie gedagtes is en dat dit nie van 














In die laaste maand, het u dinge herhaaldelik gedoen sonder dat u kon ophou, 
soos om oordadig te was of  skoon te maak, om dinge oor en oor te tel of te 
kontroleer, of herhaling, versameling, rangskikking van dinge, of ander  






























Het u opgelet dat hierdie obsessiewe gedagtes en / of kompulsiewe gedrag 













Het hierdie obsessiewe gedagtes en / of kompulsiewe gedrag beduidend 
ingemeng met u normale roetine, werksfunksionering, gewone sosiale 













      
  
IS H6 GEKODEER JA ? 
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Het u al ooit u ‘n uiters traumatiese gebeurtenis wat dood of dreigende dood 
of ernstige besering aan u of iemand anders insluit, ervaar of aanskou of 
moes u dit hanteer? 
VOORBEELDE VAN TRAUMATIESE GEBEURE : ‘N ERNSTIGE ONGELUK, SEKSUELE OF 
FISIESE AANRANDING, ‘N TERRORISTE AANVAL, OM GEISELAAR GEHOU TE WORD, 
ONTVOERING, AANHOUDING, VUUR, ONTDEKKING VAN ‘N LIGGAAM, ONVERWAGSE 


















Gedurende die laaste maand, het u die gebeurtenis herleef op ‘n onstellende 















In die afgelope maand : 
 
    
 a Het u dit vermy om aan die gebeurtenis terug te dink, of het u dinge vermy 







 b Het u probleme ondervind om sekere belangrike dele van die gebeurtenis te 
onthou ? 
 NEE JA 4 
 c Was u minder geïnteresseer in u stokperdjies en sosiale aktiwiteite ?  NEE JA 5 
 d Het u afgesonder of vervreemd van ander gevoel ?  NEE JA 6 
 e Het u opgelet dat u emosies afgestomp is ?  NEE JA 7 
 f Het u gevoel dat u lewe verkort sou word a.g.v. hierdie trrauma ?  NEE JA 8 
  









In die afgelope maand : 
 
    
 a Het u probleme ondervind om te slaap ?  NEE JA 9 
 b Was u besonders geïrriteerd of het u woede uitbarstings gehad ?  NEE JA 10 
 c Het u probleme ondervind met u  konsentrasie ?  NEE JA 11 
 d Was u gespanne of gedurig op u hoede ?  NEE JA 12 
 e Is u maklik skrik gemaak ?  NEE JA 13 
  








I5 Het hierdie probleme gedurende die laaste maand, beduidend met u werk of 







      
  
IS I5  GEKODEER JA ? 
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Het u in die laaste 12 maande,  3 of meer alkoholiese drankies in ‘n 3 uur 

















In die laaste 12 maande : 
 
Was dit nodig om meer te drink om sodoende dieselfde effek te kry as toe u 



















Het u hande gebewe, het u gesweet of het u geagiteerd gevoel wanneer u 
minder gedrink het ? 
Of, het u gedrink om hierdie simptome te verhoed of om te voorkom dat u 
babelas raak b.v.  «die bewerasies» , sweterigheid of agitasie ? 



















Gedurende die tye wat u alkohol gebruik het, het u meer gebruik as wat u 























Op die dae wat u gedrink het, het u ‘n aansienlike tyd  daaraan spandeer om 














Het u minder tyd spandeer aan werk of om u stokperdjies te geniet, of saam 













Het u aanhou drink al het u geweet dat dit nadelig vir u  fisiese en geestelike 










      
  
IS 3 OF MEER J2 ANTWOORDE GEKODEER JA ? 
 
 
   






      
  








J3 In afgelope12 maande : 
 
    
 a Was u geïntoksikeerd, hoog, of babelas toe ander verantwoordelikhede by 
die skool, werk of tuis gehad het? Het dit vir u probleme veroorsaak ?  
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Was u geïntoksikeerd in enige situasie waar u fisies in gevaar was, b.v. 














Het u enige probleme met die gereg gehad a.g.v. u alkohol gewoontes, b.v., 
























      
  
IS 1 OF MEE J3 ANTWOORDE GEKODEER JA ? 
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AMFETAMIEN PETROL MORFIEN 
CANNABIS GOM OPIUM 
KOKAIEN DAGGA PALFIUM 
KODEÏEN HASHISH PCP 
CRACK HEROÏEN RITALIN 
DICONAL LSD TEMGESIC 
ECSTASY MARIJUANA THC 
ETER MESCALINE TOLUENE 
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Nou gaan ek vir u vir u wys  (WYS DIE KAART MET DIE SUBSTANSE ) / vir u 
‘n lys lees (LEES DIE LYS) van straat dwelms of medikasies. In die laaste 12 
maande, het u enige van hierdie middels meer as een maal geneem om hoog 

















 OMKRING ELKE MIDDEL WAT GEBRUIK IS : 
 
Stimulante : amfetamines, « speed », crystal meth, « rush », Dexedrine, Ritalin, dieet pille. 
Kokaïen : snorting, IV, freebase, crack, « speedball ». 
Narkotika : heroin, morfien, dilaudid, opium, demerol, methadone, kodeien, percodan, darvon. 
Hallusinogene : LSD (« acid »), mescaline, peyote, PCP (« angel dust », « peace pill »), 
psilocybin, STP, « mushrooms », ecstasy, MDA, or MDMA. 
Inhalante : « gom », etiel kloried, stikstof, (« laggas »), amiel of butiel nitraat (« poppers »). 
Marijuana : hashish (« hash »), THC, « pot », « grass », « weed », « reefer », dagga. 
Kalmeermiddels : quaalude, Seconal (« reds »), Valium, Xanax, Librium, Ativan, Dalmane, 
Halcion, barbiturate, Miltown. 
Allerlei: steroïede, nie-voorgeskrewe slaap of diëet pille. Enige ander ? 
 












SPESIFISEER IN DIE KRITERIA HIER ONDER, WAT ONDERSOEK SAL WORD : 
• INDIEN  GELYKTYDIG OF OPVOLGENDE POLI-SUBSTANS GEBRUIK : 
 ELKE MIDDEL (OF MIDDEL KLAS) AFSONDERLIK GEBRUIK 
 MIDDEL (OF  MIDDEL KLAS) DIE MEESTE GEBRUIK 
• INDIEN EEN MIDDEL (OF MIDDEL KLASIFIKASIE) GEBRUIK : 














K2 In ag genome die gebruik van [NOEM DIE SPESIFIEKE MIDDEL / MIDDEL KLAS] 
in  die laaste 12 maande: 




Het u gevind dat u nodig gehad het om meer van  [NOEM DIE MIDDEL OF 














Toe u verminder het of gestop het om die [NAAM VAN MIDDEL OF MIDDELKLAS] 
te gebruik het u onttrekking simptome (pyn, bewe, koors, swakheid, diarree, 
naarheid, sweet, hartkloppings, probleme om te slaap , agitasie, angs, 
irritasie of depressie) ervaar ? 
Of het u enige middels gebruik om te voorkom dat u siek  
(ONTTREKKINGSSIMPTOME) word of om beter te voel ? 




























Het u ooit ondervind dat wanneer u [NAAM VAN MIDDEL  OF MIDDEL KLAS] 
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Het u probeer om op te hou of minder [NAAM VAN MIDDEL OF MIDDEL KLAS]  te 












    e 
 
Op die dae wat u [ NAAM VAN MIDDEL OF MIDDEL KLAS ] gebruik het, het u 
‘n substansiële tyd (< 2  uur ) daaraan spandeer om dit te bekom, te gebruik 
















Het u minder tyd aan u werk, stokperdjies of saam met u familie of vriende 













Het u aangehou om die [NAAM VAN MIDDEL OF MIDDEL KLAS] te gebruik 










      
  
IS 3 OF MEER K2 ANTWOORDE GEKODEER JA ? 
 
SPESIFISEER MIDDEL(S) : 
________________________________________________ 
   



















K3 In die laaste 12 maande : 
 
    
 a Was u geïntoksikeerd, hoog, of babelaas van [NAAM VAN MIDDEL OF MIDDEL 
KLAS], meer as een maal wanneer u ander verantwoordelikhede gehad het by 
die skool of werk of tuis ? Het dit enige probleme veroorsaak ? (SLEGS JA 
















Was u hoog of geïntoksikeerd van [NAAM VAN MIDDEL OF MIDDEL KLAS] in 
enige situasie waar u fisies ingevaar was (b.v. motor bestuur, of ‘n 













Het u enige geregtelike probleme gehad a.g.v. die gebruik van [NAAM VAN 













Het u aangehou om [NAAM VAN MIDDEL OF MIDDEL KLAS] te gebruik al het dit 














IS 1 OF MEER K3 ANTWOORDE GEKODEER JA ? 
 
SPESIFISEER MIDDEL(S) : 
________________________________________________ 
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L. PSIGOTIESE STEURINGS  
 
VRA VIR ‘N VOORBEELD VAN ELKE VRAAG WAT JA BEANTWOORD IS. MERK  JA SLEGS INDIEN DIE VOORBEELD 
DUIDELIK WYS DAT DAAR ‘N  STEURING IN GEDAGTES OF PERSEPSIE IS OF INDIEN DIT NIE KULTUREEL TOEPASLIK IS NIE 
. 
VOORDAT U DIT MERK, ONDERSOEK  EERS OF DIE WANE AS « BISAR » BESKOU KAN WORD. 
WANE IS BISAR INDIEN : DUIDELIK  ONMOONTLIK , ABSURD, NIE VERSTAANBAAR  EN KAN NIE  SPRUIT UIT 
NORMALE LEWENS ERVARINGE NIE. 
HALLUSINASIES IS BISAR INDIEN : ‘N STEM KOMMENTAAR LEWER OP ‘N PERSOON SE GEDAGTES EN GEDRAG, OF 
INDIEN TWEE OF MEER STEMME MET MEKAAR  ‘N GESPREK VOER. 
 
  
Nou gaan ek u uitvra oor ongewone ervarings wat sekere individue mag 
ervaar. 
     
     BISAR  
L1a Het u al ooit geglo dat iemand op u spioneer of dat iemand ‘n komplot teen u 










 b INDIEN JA : Glo u tans hierdie dinge ? 
 




L2a Het u al ooit geglo dat iemand u gedagtes kan lees of  hoor of dat u iemand 














Het u al ooit geglo dat iemand, of ‘n mag buite u, gedagtes in u kop plaas 
wat nie u eie is nie, of u laat optree op ‘n manier wat nie uself is nie ? Het dit 

















L4a Het u al ooit geglo dat spesiale boodskappe vir u deur die TV, radio of 
koerant gestuur word of dat ‘n persoon wat u nie persoonlik ken nie 


















L5a Het u familie of vriende ooit enige van u menings of oortuigings vreemd of 
onrealisties gevind ?  
ENIGE WANE WAT NIE ONDERSOEK IS IN VRAAG  L1 TOT  L4, B.V. VAN GRANDIOSE, 









 b INDIEN JA : Beskou hulle tans u menings en oortuigings as vreemd ? 
 
 NEE JA JA 
 
10 
L6a Het u al ooit dinge gehoor wat ander nie kan hoor nie, soos stemme ? 
HALLUSINASIES IS « BISAR » SLEGS INDIEN DIE PASIËNT JA OP DIE VOLGENDE 
ANTWOORD: 
Het u ‘n stem gehoor wat kommentaar lewer op u gedagtes of gedrag, of het 
u twee of meer stemme gehoor wat met mekaar praat ? 
 NEE JA JA 11 
 b INDIEN JA : Het u hierdie dinge in die laaste maand gehoor ?  
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L7a Het u al ooit visioene ervaar of dinge gesien wat ander nie kan sien nie 
terwyl u wakker was ? 














OORDEEL/ MENING VAN ONDERVRAER : 
 
TOON DIE PASIËNT TANS ONSAMEHANGENDHEID, GEDISORGANISEERDE SPRAAK, OF 

















L9b TOON DIE PASIËNT TANS GEDISORGANISEERDE OF KATATONIESE GEDRAG ? 
 
 NEE JA 16 
L10b IS DIE NEGETIEWE SIMPTOME VAN SKISOFRENIE B.V. BEDUIDENDE AFGESTOMPTHEID, 
ARMOEDE VAN SPRAAK (ALOGIA) OF ‘N ONVERMOË OM ‘N DOELGERIGTE AKTIWITEIT 














VAN L1 TOT L10 : 
• IS 1 OF MEER « b » VRAE JA BISAR ? 
OF 
• IS 2 OF MEER « b » VRAE JA (EERDER AS JA BISAR) ? 
   





      
L12 VAN L1 TOT L7 : 
• IS 1 OF MEER « a » VRAE GEKODEER JA BISAR ? 
OF 
• IS 2 OF MEER « a » VRAE GEKODEER JA (EERDER AS JA 
BISAR) ? 
(KONTROLEER DAT DIE 2 SIMPTOME GEDURENDE DIESELFDE TYDPERK   
VOORGEKOM HET) 
OF 
• IS L11 GEKODEER JA ?  
   





      
L13a INDIEN L11 JA IS OF TEN MINSTE EEN JA VAN L1 TO L7 : 
 
IS DIE PASIËNT POSITIEF VIR ‘N 
 MAJOR DEPRESSIEWE EPISODE (HUIDIG OF IN DIE 
VERLEDE) 














b INDIEN L13a JA  
U het my vroeër vertel dat u ‘n periode(s) gehad het toe u (depressief/ hoog/ 
aanhoudend geïrriteerd) gevoel het. Was die  ervarings wat u  beskryf het 
(SIMPTOME  JA VAN L1 TOT L7) eksklusief beperk tot tye toe u  depressief / 
















    
  
IS L13b GEKODEER JA ? 
   
 NEE JA 
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Cm ÿ   
 
      b 
 
Wat was u laagste gewig in die laaste 2 maande ? 
  
|__|__|__| Lbs. ÿ 
Kg ÿ 
 
      c 
 
IS DIE PASIENT SE GEWIG LAER AS DIE OOREENSTEMMENDE DRUMPEL 


















In die laaste  3 maande : 
 
















Het u dit gevrees om gewig op te tel of om vet te word, alhoewel u onder 





























































SLEGS VIR DAMES : Gedurende die laaste 3 maande, het u al u menstruele 
periodes oorgeslaan op die datum wat hulle veronderstel was om voor te 










      
  
VIR DAMES : IS M5 EN M6 GEKODEER JA ? 
VIE MANS : IS M5 GEKODEER JA ? 
 
 
   





    
 
TABEL LENGTE / GEWIGS DRUMPEL (LENGTE-SONDER SKOENE ; GEWIG- SONDER KLERE) 
LENGTE (cm) 140 145 150 155 160 165 170 175 180 185 190 
Dames 37 38 39 41 43 45 47 50 52 54 57 
GEWIG (kg)            
Mans 41 43 45 47 49 51 52 54 56 58 61 
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In die laaste drie maande, het u eet »binges» of tye wanneer u ‘n baie groot 
















In die laaste 3 maande, het u eet  binges» so gereeld as twee maal per week 






























Het u enige iets gedoen om te verhoed of te kompenseer vir gewigs toename 
na hierdie «binges», soos om te vomeer, lakseer middels te gebruik, te vas, 








































Kom hierdie «binges» slegs voor wanneer u onder ______kg/lbs.* is ? 
* NEEM DIE DRUMPELGEWIG VIR DIE PASIËNT SE LENGTE / GEWIG TABEL IN 







      
  
IS N5 JA EN N7 NEE (OF OORGESLAAN) ? 
 
 
   





    
  
IS N7 GEKODEER JA? 
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O. ALGEMENE ANGSSTEURING 
 
 









      b 
 
Was u oormatig bekommerd of gespanne oor verskeie dinge van die 
daaglikse lewe, by die werk, by die huis of in u nabye kring gedurende die 
laaste 6 maande ?  
 
MOENIE JA MERK INDIEN DIE FOKUS VAN DIE ANGS BEPERK IS TOT ‘N ANDER 
STEURING WAT VOORHEEN ONERSOEK IS, SOOS OM ‘N PANIEK AANVAL TE KRY 
(PANIEKSTEURING ) , OM IN DIE  PUBLIEK VERLEË TE WEES (SOSIALE FOBIE ), GEWIG 
OP TE TEL (ANOREXIA NERVOSA) , OM GEKONTAMINEER TE WORD (OKS )... 
 







































Vind u dit moeilik om die bekommernisse te beheer of meng dit in met u 
















VAN O3a TOT O3f, MERK DIE SIMPTOME WAT BEPERK IS TOT ENIGE 
STEURING WAT ONDERSOEK IS VOOR HIERDIE PUNT  NEE . 
 
Wanneer u angstig was gedurende die laaste 6 maande, het u , omtrent 
elke dag : 
 






















































Probleme gehad om te slaap (moeilik aan die slaap geraak,in die middel van 












     
  
IS 3 OF MEER O3 ANTWOORDE GEKODEER JA ? 
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 a Herhaaldelik stokkies gedraai of weggehardloop van die huis gedurende die 
nag ? 
 
 NEE JA 1 
 b Herhaaldelik leuns vertel, bedrieg, gesteel of ander om die bos gelei ? 
 
 NEE JA 2 
 c Gevegte begin of ander geboelie, gedreig of geïntimideer ? 
 
 NEE JA 3 
 d Doelbewus dinge verniel of vure begin ? 
 
 NEE JA 4 
 e Doelbewus diere seer gemaak ? 
 
 NEE JA 5 
 f Iemand geforseer om seks te hê ? 
 
 NEE JA 6 
  









MOENIE JA MERK INDIEN DIE GEDRAG HIERONDER UITSLUITLIK POLITIES OF 
GODSDIENSTIG GEMOTIVEER IS NIE 
 
Vandat u 15 jaar oud was, het u : 
 
    
 a Herhaaldelik opgetree in ‘n manier wat andere as onverantwoordelik beskou 
het, soos om nie te betaal vir dinge wat u skuld nie, om doelbewus impulsief 














 b Dinge gedoen wat onwettig was al is u nie gevang nie (b.v., eiendom verniel, 








 c Gedurig betrokke geraak in fisiese gevegte (insluitend fisiese gevegte met u 








 d Dikwels gejok of ander om die bos gelei om geld of plesier te verkry, of 








 e Ander aan gevaar bloot gestel sonder om om te gee ? 
 
 NEE JA 11 
 f Nie skuldig gevoel nadat u iemand seer gemaak het of sleg behandel het nie, 









    
  
IS 3 OF MEER ITEMS VAN P2 GEMERK JA ? 
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Objective: It is unclear whether changes in hippocampal volume after trauma 
exposure are due to trauma or its psychiatric sequelae, and there are few data 
available on white matter integrity after trauma exposure.  This study aimed to 
examine hippocampal volume and white matter tracts in women with and without 
exposure to intimate partner violence (IPV), while controlling for comorbidity. 
 
Methods: 19 women with IPV exposure in the last year, and 21 women without IPV 
exposure in the last year underwent structural magnetic resonance imaging (MRI) 
including diffusion tensor imaging (DTI) sequences. Additional data on alcohol use 
and presence of psychiatric disorder was collected. Differences in fractional 
anisotropy (FA) between the two groups were examined in relation to demographic 
measures, alcohol use and psychiatric disorder. 
 
Results: IPV subjects did not demonstrate significantly different hippocampal 
volumes compared to subjects without recent IPV. The FA was significantly reduced 
in the body of the corpus callosum of the IPV subjects. Adjusting for age, alcohol use, 
smoking and psychiatric diagnosis did not change the significance of the result. 
 
Discussion: The finding of no difference in hippocampal volume between the two 
groups is consistent with some studies. However, other studies examining trauma 
exposure without PTSD report on reduced hippocampal volumes in these subjects. It 
is possible that the severity of trauma or IPV exposure is one of the moderating 
factors in hippocampal volume changes. The finding of reduced FA in the body of the 
corpus callosum suggests altered integrity of this white matter tract in women 
exposed to IPV. The origin of this abnormality remains unclear. Our combined 
















Intimate partner violence (IPV) is a global public health problem. Population-based 
surveys from North America indicate that 1 in 4 women have  experienced IPV in 
their lifetime, and 1 in 10 are current victims [1-2]. Similarly, a cross-sectional survey 
from South Africa found that the lifetime prevalence of women experiencing IPV was 
24.6% , and 9.5% in the last year [3]. The high prevalence of adverse physical and 
mental health outcomes related to IPV is well established in the research literature 
[4-6]. In a review of mental health outcomes of women with IPV, victims of partner 
violence were up to 5 times more likely to develop depression, suicidality, PTSD and 
substance abuse compared to non victims [7]. 
 
Brain imaging has been used to explore the neurobiological correlates of trauma 
exposure. There is however, a dearth of neurological studies that specifically 
examine women with exposure to intimate partner violence. Some studies 
investigating PTSD in women have specifically recruited subjects with IPV exposure 
[8-11]. In one such study, the authors report that women exposed to IPV display 
deficits in executive functioning, working memory and visuoconstruction [11]. In 
another study, women with IPV were found to have smaller supratentorial cranial 
vault volumes that was largely due to reduced mesial temporal  grey matter 
particularly in the parahippoocampal region, and reduced frontal and occipital grey 
matter regions [10]. Taken together, these findings suggest that frontal subcortical 
networks are implicated in women exposed to violence which corresponds with 
deficits in cognitive tasks that utilise these pathways. In another study, the neuronal 
integrity of the anterior cingulate in women with IPV was examined using single voxel 











measures of executive functioning that are thought to rely on the intact functioning of 
the anterior cingulate [9].  Interestingly, there was no difference in metabolite ratios in 
the anterior cingulate of IPV subjects relative to controls. The IPV subjects displayed 
deficits in executive functioning; however, there was no significant relationship 
between the metabolite ratios and the measures of executive functioning. These 
findings are inconsistent with several previous functional neuroimaging studies of the 
anterior cingulate in PTSD subjects [12-14], and, with the only other study of 
neuronal metabolites N-acetylaspartate (NAA) in the anterior cingulate of subjects 
with PTSD, which reported on reduced NAA/Creatine in the anterior cingulate of 
maltreated children and adolescents with PTSD relative to traumatized subjects 
without PTSD [15]. It therefore remains unclear whether changes in the anterior 
cingulate are a unique feature of paediatric PTSD, or whether other brain structures 
are involved in IPV related exposure. 
 
It is clear from the literature that neuroimaging studies of women exposed to IPV 
require replication. Furthermore, there are no studies that have examined white 
matter (WM) tracts in women with IPV. Given the discrepant findings of abnormalities 
in the hippocampus in women with IPV, examining the WM tracts that connect 
frontal-subcortical brain areas, may shed light on the effects of IPV on female brain 
structure. In light of limited neurobiological data on the effects of IPV exposure in 
women, our study aimed to evaluate hippocampal volume and the integrity of WM 






Forty women were recruited from a rural community north of Cape Town. Subjects 











spectrum disorder through a series of brief interventions to change drinking 
behaviour in pregnant women [16]. We selected this sample on the basis of the high 
prevalence of alcohol abuse and IPV in that area. In addition, the field worker was 
familiar with these women through her work in the main study, which made it easier 
to recruit subjects given the sensitive nature of our study. Inclusion criteria were 
women aged 16 to 65 years. Subjects were excluded if  1) they were pregnant, 2) 
MRI was contra-indicated, 3) there was a history of a neurological disorder, including  
previous head injury, epilepsy, or cerebrovascular disease, or 4) current medical 
illness. 
Interview 
 All participants were seen by a psychiatrist who completed the following 
questionnaires. The Abuse Assessment Screen (AAS) was used to classify 
participants as cases or controls: cases (n=19) were defined as women who reported 
IPV in the last year (score >1), and controls (n=21) were defined as women with no 
reports of violence in the previous year. The Alcohol Use Disorders Identification Test 
(AUDIT) and the Mini International Neuropsychiatric Interview (MINI), were used to 
obtain additional data on alcohol use, and to screen for the presence of psychiatric 
disorders, in particular PTSD and major depression. All participants gave written 
informed consent to participate in the study, which was approved by the University of 
Cape Town Research Ethics Committee. 
  
MRI scanning 
Scanning took place at the Cape Universities Brain Imaging Centre (CUBIC) in 
Tygerberg Hospital.  Images were acquired using a 3 Tesla Siemens Allegra MRI 
scanner.  Scans were taken up to 12 months post delivery to allow for any pregnancy 
related changes to resolve. T1 MPRAGE images were acquired in the sagittal plane 
with the following parameters:  TR = 2200, TE = 5.2, FOV = 256 x 256 and 160 slices 











were obtained and each average consisted of 30 diffusion directions with b=1000 
mm/s2, 3 b=0 mm/s2 images, TR = 8800 and TE = 88. The images were acquired as 
a mosaic (960 x 960 matrix) with 60 slices per volume and a slice thickness of 2.2mm 
 
 
Hippocampal volume measurements 
The FSL software package FIRST (FMRIB’s integrated registration and segmentation 
tool) was used to determine volume and shape differences for the left and right 
hippocampus [17,18]. The process is as follows: the T1 images of each subject are 
transformed to Montreal Neurological Institute (MNI) 152 space by a 12-degree affine 
transformation. After the subcortical structures are aligned, a subcortical mask is 
applied to locate the different subcortical regions. Segmentation of these regions is 
then performed according to standardized shape models and voxel intensities. The 
absolute volumes of the individual structures are calculated, taking into account the 
transformation parameters of the initial registration. For this study, a boundary 
correction was applied to the hippocampus to determine which voxels along the 
boundary belong to the structure. A correction with a z-value of 3 was used. The 
segmentations and registrations were examined for any misregistration.  A vertex 
statistical analysis was performed on the segmented hippocampus for each subject 
to examine whether there were any significant differences in hippocampus structure 
and shape between cases and controls. A total of 2 control and 4 IPV subjects were 
excluded from this analysis because of problematic registration and artefacts in the 
left hemisphere of the brain. Thus the final analysis was performed on 19 control 
subjects and 15 IPV cases.  
 











Diffusion tensor imaging (DTI) is a non-invasive MRI technique that enables the 
measurement of the diffusion of water in tissue in order to produce white matter 
(WM) images. Fractional anisotropy (FA) is the quantitative measure of the 
directionality of diffusion which varies from zero (diffusivity equal in all directions) to 
one (entirely unidirectional). FA measures in DTI are indices of WM integrity. 
 
 Post-processing: Tract-based spatial statistics (TBSS) white matter FA analysis. 
The whole analysis was performed in the FMRIB’s software library (FSL) [19]. For the 
data analysis, fractional anisotropy (FA) and mean diffusion (MD) maps were created 
by firstly doing brain extraction (BET) and then fitting a tensor model to the raw 
diffusion data using FMRIB’s Diffusion Toolbox (FDT) [20]. The subjects FA data 
were aligned into a common space using the non-linear registration tool FNIRT [21]. 
The mean FA image was then  created and thinned to create a mean FA skeleton 
that represents the centres of all white matter (WM) tracts common to the group. 
Each subject’s aligned FA data were then projected onto the skeleton and resulting 
data fed into voxelwise cross-subject statistics. A two-tailed unpaired t-test with 
threshold-free cluster enhancement was used for the two groups. Only clusters that 





The demographic variables in Table 1 were measured at entry to the larger study. 
There was no significant difference in demographic data between subjects with 
recent IPV exposure and control subjects.  
 
The group of women who reported IPV in the previous year, scored significantly 











significantly greater in the IPV subjects relative to those women without reports of 
IPV in the previous year (p 0.003). Table 2. 
 
IPV FIRST hippocampus volume analysis 
A surface FDR correction for multiple comparisons was performed on the vertex 
maps of the left and right hippocampus. There was no significant difference in 
volume between IPV subjects and controls (p>0.05)  
 
Fractional anisotropy (FA) was significantly reduced in the body of the corpus 
callosum only, in the IPV exposure subjects (p 0.0003). Figure 1. 
 Age, smoking, alcohol and psychiatric diagnosis can affect white matter tracts. For 
this reason age, smoking status, alcohol use and presence of psychiatric diagnosis 
were adjusted in the analysis, but this did not impact on the finding. Table 3 
 
Discussion 
This study yielded several findings. First, women with recent IPV use more alcohol 
and experience more psychiatric morbidity than women without recent IPV exposure. 
Second, the hippocampal volume in women with IPV is not reduced compared to 
women without IPV exposure in the last year. Third, a change in the integrity of WM 
tracts in the body of the corpus callosum is seen in women exposed to interpersonal 
violence. Fourth, the abnormality in the WM tracts of the corpus callosum in IPV 
subjects could not be accounted for by alcohol use or psychiatric diagnosis. 
 
The adverse mental health sequelae of IPV are well documented in the literature [22-
27]. Similarly, in our study, women with IPV exposure used more alcohol (26.3% 
alcohol dependence, 10.5% alcohol abuse) and had more psychiatric diagnoses 












Previous literature on hippocampal volume after exposure to IPV has been 
inconsistent. One the one hand,  a series of meta-analyses of structural brain 
abnormalities in PTSD, ( 6 studies, N=175) that compared hippocampal volume in 
persons exposed to trauma without PTSD and healthy  controls (HC) reported that 
the trauma exposed non-PTSD subjects had significantly smaller bilateral 
hippocampal volumes compared to the HC subjects [28]. However, our negative 
finding is in keeping with data from several neuroimaging studies of PTSD subjects 
[10, 29-31]. 
 
One question is whether decreased hippocampal volume in PTSD is due to trauma 
exposure (such as IPV), or due to PTSD.  Although only 1 of the 19 IPV-exposure 
subjects had PTSD in our study, in a similar study where half the IPV exposure 
subjects had PTSD, PTSD status did not significantly change the finding that 
hippocampal volume was not reduced [10]. Given that age, gender and PTSD 
severity, (which is plausibly genetically mediated) are some of the moderators of 
reduced hippocampal volume in subjects with PTSD, it is possible that the differential 
effects on brain structure can be accounted for by different types of stress exposure 
(combat versus interpersonal) or different sample compilations (male and female 
versus studies with only female subjects).  
 
The corpus callosum is the largest white matter (WM) fibre bundle in the brain. 
Corpus callosum fibres connect corresponding areas of cortex between 
hemispheres. Given that the FA measurement error is lowest in regions with 
intrinsically high anisotropy, like the corpus callosum [32], it is more likely that our 
finding of significantly reduced FA in the body of the corpus callosum of IPV 
exposure subjects represents altered white matter integrity. It is also possible that our 













 Several studies of paediatric PTSD have consistently reported FA reductions in the 
corpus callosum [33, 34]. Changes in the corpus callosum in paediatric PTSD are 
thought to be due to atrophy or neurodevelopmental deficits as a result of trauma 
exposure. This theory is supported by animal studies that describe abnormalities in 
the corpus callosum in male monkeys exposed to prenatal stress [35]. In a recent 
study using DTI, A.P. Jackowski et al report on reduced corpus callosum in 
maltreated children with PTSD, but conclude that it is impossible to say whether the 
changes in the corpus callosum are a function of PTSD or of maltreatment as all 
subjects had PTSD secondary to physical abuse, sexual abuse or exposure to 
domestic violence [36]. Similarly, in our study childhood trauma was not measured, 
therefore it is possible that the changes we report on in the corpus callosum , are as 
a result of childhood trauma. Another consideration might be, given that women with 
IPV exposure experience more psychiatric disorders including alcohol, relative to 
women without IPV exposure, might suggest that the morphological differences in the 
corpus callosum are  due to developmental or genetic factors that predispose these 
individuals  to mental health problems. However, alcohol use and psychiatric 
diagnosis was explored in our covariate analysis, and found not to significantly alter 
the result.  
 
The corpus collosum plays a role in visuomotor integration and may interact in 
important ways with subcortical structures, notably basal ganglia, in response 
initiation [37].  Injury may be reflected in slowed response initiation and longer 
reaction times on tasks involving hemispheric transfer or integration between regions. 
Changes in the integrity of this structure may be associated with less efficient 
compensatory mechanisms. Although we did not perform neuropsychological tests, 
these data correlate with visuoconstruction deficits reported in women with IPV [11]. 











combine neuroimaging and neuropsychological data to see whether changes in 
corpus callosum integrity correlate with deficits in visuomotor integration. Further 
work is also required to elucidate the clinical significance of corpus callosum changes 
in women with IPV.  
 
The significance of our findings is limited by, first the lack of longitudinal trauma data, 
and other variables like medication use, which is known to affect both grey and white 
matter brain structures. Second, IPV was only measured using the Abuse 
Assessment Screen (AAS) during a face to face interview. Administering the 
Conflicts Tactics Scale (CTS) in addition to the AAS, would improve the reliability of 
the measure of IPV and yield more information on the type and severity of 
interpersonal violence, which are important factors in determining ill health following 
IPV. The problem of possible under reporting of IPV during a face to face interview 
might be addressed through an anonymous self report questionnaire. 
 
In summary, our study found that the corpus callosum was altered in women who 
reported interpersonal violence, while no difference was seen in the hippocampus. 
Further research is needed to replicate our findings. Integrative biobehavioural 
methodologies that combine  neuropsychological testing with neuroimaging for 
example could be used to shed light on the clinical significance of abnormalities 
found in research settings in women with IPV. A greater understanding in this area 
may ultimately lead to improved treatments. 
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interventions to change drinking behaviour for the prevention of fetal alcohol 




































Variable Controls n=21 
Mean or % 
IPV Cases n=19 
Mean or % 
P-Value 
Age 25.4 22.1 0.094 
Primary school 
education only 
42.9 26.3 0.271 
Further training 
after school 
14.3 10.5 0.719 
Employed 52.4 36.8 0.323 
Live in town 76.2 89.5 0.262 
In a relationship 52.4 63.2 0.490 
Pregnant more 
than once 
52.4 52.6 0.987 













Variable Contols n=21 
Mean(%) 
IPV Cases n=19 
Mean (%) 
P-Value 
Audit score 2.5 11.2 0.001 
MINI 14.3 57.9 0.003 
MDD 1 (4.8) 6 (31.6)  
Dysthymia 0 1 (5.3)  
PTSD 0 1 (5.3)  
GAD 0 1 (5.3)  
SAD 1 (4.8) 0  
Agoraphobia 2 (9.5) 0  
Alcohol abuse 0 2 (10.5)  
Alcohol 
Dependence 
0 5 (26.3)  
Metamphetamine 
dependence 

































Anatomy: Body of the corpus callosum 
Hemisphere: Bilateral 
MNI coordinates: X 91, Y 130, Z 96 
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Neurological studies of women with intimate partner violence 
 
 
Intimate partner violence (IPV) is a global public health problem associated with 
significant morbidity. Epidemiologic studies estimate that 10-69% of women 
worldwide report IPV at some point in their life [1]. Psychiatric disorders commonly 
follow IPV exposure, particularly major depressive disorder, posttraumatic stress 
disorder (PTSD) and alcohol abuse. These sequelae contribute significantly (95%) to 
the burden of disease of IPV [2]. A better understanding of the mechanisms that lead 
to or protect against mental disorders following IPV exposure, may improve the 
treatment and management of these disorders.  
 
 Structural and functional neuroimaging is one approach to examine the 
neurobiological effects of IPV exposure.   The objective of this paper is determine 
what is already known about the effects of interpersonal violence on the female brain, 
by reviewing all neurological studies that have examined women with IPV exposure.  
The evidence for the neurological correlates of IPV in women was obtained by 
searching PubMed and PsychInfo using the terms “ intimate partner violence”, “IPV 
related PTSD”,  “neuroimaging”, “brain changes”, “ neural correlates” and 
“neurological” . Studies of women only as recipients of IPV were selected from 
English language journals. No limits were placed on dates and all study designs were 
considered in light of the paucity of data in this area. Four studies matched the 


















Table 1 Neurological studies of women with IPV 








PTSD +, 22 












PTSD +, 11 

























a= non-traumatised controls  
b= quantative magnetic resonance imaging  
c= single voxel proton magnetic resonance spectroscopy  
d= functional magnetic resonance imaging 
 
 
There is general consensus from the research literature that individuals with PTSD 
display cognitive deficits. However, the types of cognitive deficits observed have 
varied across studies. Similarly, the literature is inconsistent regarding whether the 
cognitive deficits in subjects with PTSD are a feature of trauma exposure, or PTSD or 
an existing risk factor for both.  The aim of Stein et al’s study was to describe various 
domains of neuropsychologic function in 3 groups of women: those experiencing IPV 
who have developed PTSD, those experiencing IPV who have not developed PTSD 
and those who have not experienced IPV [3]. A total of 39 subjects with IPV (22 with 
current PTSD) and 17 non-victimized comparison (NC) subjects were recruited 
through advertisements and contacts with community services specialising in 












educational level and socioeconomic status. Exclusion criteria included history of 
psychotic disorder, drug and alcohol abuse, neurological disorders and current use of 
psychotropic medication.  A number of standardised diagnostic tests and 
neuropsychological measures were applied to IPV and NC subjects (Table 2 and 3). 
 
Table 2 
Diagnostic and symptom severity measures 
Test Assesses 
CAPS (Clinician administered PTSD 
scale for DSM-IV) a 
Presence and severity of PTSD 
(questions directed towards experiences 
of domestic violence) 
PTSD, major depressive disorder, panic 
disorder, generalised anxiety disorder 
modules of SCID-P (Structured clinical 
interview for DSM-IV) b 
Presence or absence of lifetime PTSD 
for any trauma other than domestic 
violence, presence of depression, panic 
disorder or generalised anxiety disorder 
Center for Epidemiologic Studies-
Depression Scale (CES-D) c 
Level of depression in the previous week 
Impact of event scale-Revised (IES-R) d 
 
Severity of PTSD symptoms over the 
week before testing 
Revised version Conflicts Tactics Scale 
(CTS-2) e 
 
Severity of IPV 




a Blake et al,1995 
b First et al 1997 
c Radloff 1977 
d Weiss and Marmar 1997 
e Strauss et al 1996 















Table 3  
Neuropsychological tests 
 
Cognitive Domain Test 
Attention and Working Memory Wechsler Adult Intelligence Scale-III 
(WAIS-III) Digit Span subset a 
Auditory Consonants Trigrams b 
 
Psychomotor Speed Part A of the Trail Making Test c 
Verbal learning and memory California Verbal Learning Test d 
Verbal Paired Associates e 
Logical Memory subset of WAIS-III f 
Visuoconstruction and Visual memory Continuous Visual Memory Test g 
Rey-Osterrieth Complex Figure Test h 
Language  Controlled Oral Word Association Test h 
Vocabularly subset of WAIS-III a 
Executive function Part B of the Trail Making Test c 
Category Test e 
Stroop Colour-Word Interference Test i 
 
a  Wechsler 1997a 
b  Lezak 1995 
c  Hays 1995, Reitan 1992 
d Delis et al 1987 
e Reitan and Wolfson 1993 
f  Weschler 1997b 
g Trahan and Larabee 1988 
h Spreen and Strauss 1998 















The key findings from this study [3] are firstly that women with IPV, regardless of 
PTSD status, demonstrated uniformly similar cognitive deficits. In the IPV group, 
cognitive deficits were seen in measures of working memory, visuoconstruction, and 
executive functioning. In contrast to other studies of PTSD [7], there was no evidence 
for deficits in verbal learning or memory in the IPV subjects. 
 
Secondly, although the PTSD + subjects had higher scores on measures of PTSD, 
dissociative and depressive symptoms and had been exposed to more severe IPV, 
no consistent relationship was found between these measures and any of the 
neuropsychological tests. This finding is in contrast to results from studies of male 
Vietnam veterans with PTSD and cognitive impairment [8]. The authors suggest that 
the small sample size, the difference in the subjects sampled (male versus female), 
and the difference in exposures (combat versus interpersonal violence), may account 
for the inconsistency in results.  Furthermore, the neuropsychological differences 
may be explained by pre-existing differences in cognitive function that are more 
common in persons at risk of IPV.  
 
In the second study under review, Fennema-Notestine et al  examine brain 
morphometry in  22 women with recent IPV exposure (11+PTSD and 11 - PTSD) and 
in 17 women without significant trauma histories (NC) to test the hypothesis that the 
hippocampus is smaller in the group of women with IPV + PTSD [4]. The subjects in 
this neuroimaging  study were part of the larger neuropsychological study already 
described above.  Using magnetic resonance imaging (MRI), 3 mesial temporal lobe 
structures were analysed, the hippocampus, amygdala and parahippocampal gyrus. 
In addition, whole brain fluid volume and grey and white matter volumes were 













Summary of results:  Brain morphometry in female victims of intimate partner 
violence with and without posttraumatic disorder [4] 
1. Bilateral hippocampal volume did not differ significantly between the 
IPV+PTSD group and the NC and IPV-PTSD groups. Even after controlling 
for different head sizes using supratentorial cranial vault volumes (STCN) 
proportionalised values, the results remained nonsignificant (p>0,05) 
2. IPV group (N=22) displayed smaller STCN volumes compared to NC even 
after controlling for age and education level. 
3. Raw volume measures of other mesial temporal lobe structures (amygdala 
and parahippocampal gyrus) : No significant difference was found between 
IPV+PTSD subjects and NC subjects. PTSD-IPV subjects had smaller mesial 
temporal lobes (MTL) relative to PTSD+IPV and NC subjects. This smaller 
volume in the PTSD-IPV group was mainly as a result of a larger difference in 
the right MTL grey matter, particularly in the parahippocampal region. 
     4. Cerebrospinal fluid spaces were examined first to assess whether there was        
brain volume loss in addition to smaller cerebral cranial vault size. Overall CSF 
(STCN fluid) and cortical (sulcal) fluid were not significantly different between 
groups for either raw or proportionalized (to STCN) measures. 
However, regression analyses of ventricular volumes revealed differences 
between NC and IPV groups for both raw values and for volumes 
proportionalised to STCN. In this regression model, apart from education which 
was identified as an independent significant contributor, the remaining variance is 
attributed to the difference between groups. The difference in ventricular volume 
was significant between the NC and PTSD-IPV subjects only, and this may reflect 















5. Cortical and cerebellar grey and white matter: 
Cerebrum was more affected than the cerebellum in the IPV group when the volume 
of the cerebellar cranial vault was expressed as a proportion of the volume of the 
total cranial vault (STCN plus cerebellar vault). 
Within the cerebrum, there was no difference between the NC and IPV group when 
each lobe was expressed as a proportion of the total cerebral volume (STCN grey 
and white matter). 
Regional examination of grey and white matter volumes suggested a significant 
reduction in cortical grey matter and no difference in subcortical grey matter or 
cerebral white matter volumes in the IPV group relative to the NC group. The cortical 
grey matter difference was largely attributable to smaller frontal and occipital grey 
matter regions in IPV subjects. 
 
While structural and functional imaging studies suggest several areas of dysfunction 
in subjects with PTSD, little is known about the relationship between these regional 
deficits and brain chemistry.  Magnetic resonance spectroscopy (MRS), allows for 
neuronal metabolites N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and myo-
inositol (mI) to be measured and used as a proxy measure of neuronal density.  In a 
study by Seedat et al,  single voxel proton magnetic resonance spectroscopy (1H-
MRS) was used to investigate the neuronal integrity of the anterior cingulate in 
women with IPV exposure (with and without PTSD), compared with a group of 
healthy non-traumatized controls (NC), to test the hypothesis that subjects with 
PTSD have reduced concentrations of metabolites in the anterior cingulate, and that 
these reductions in metabolites are correlated with deficits in cognitive tests of 
executive function [5]. Empirical studies have implicated the anterior cingulate in 
mediating certain core PTSD symptoms, such as heightened fear conditioning and 
difficulty prioritizing stimuli [9,10 ]. Previous positron emission tomography and 












regional cerebral metabolism in the anterior cortex [9, 11]. Furthermore, in a MRS 
study of maltreated children and adolescents with PTSD, De Bellis et al report 
significantly lower ratios of NAA to Cr in the anterior cingulate compared to healthy 
matched subjects [12]. These findings suggest that the anterior cingulate is an 
integral part of PTSD neural circuitry. 
 
In this third study under review [5], 16 women with IPV (7 with PTSD and 9 without 
PTSD) and 11 NC were recruited from community services for abused women. In 
keeping with other studies, confounding was reduced by excluding subjects with 
lifetime histories of psychotic disorders, drug and alcohol abuse and preexisting 
neurological disorders. The diagnosis of PTSD was made using the Structured 
Clinical Interview for DSM-IV Diagnosis (SCID-P), and the nature and severity of IPV 
was determined using the Conflicts Tactics Scale (CTS-2). The neurocognitive tests 
of executive functioning that were administered included Part B of the Trail Making 
Test, cognitive set shifting and the Stroop Colour-Word Interference Task, a measure 
that is thought to rely on the intact functioning of the anterior cingulate [13-15]. 
Metabolites NAA, choline (Cho) and MI were measured relative to creatine (Cr) in the 
anterior cingulated and correlated with the neuropsychological measures. 
 
The results overall yielded negative findings.  Specifically, there was no significant 
difference in metabolite ratios in the anterior cingulated between the IPV and NC 
subjects. Interestingly, the ratios of Cho and MI relative to creatine were significantly 
higher in the PTSD+IPV subjects compared to the PTSD-IPV subjects (p=0,049). 
Considering that there was no significant difference in IPV severity between women 
with and without PTSD, the authors suggest that elevated levels of choline and myo-














 On measures of executive functioning, the IPV group performed significantly worse 
compared to the NC subjects (Table 4). Contrary to the hypothesis, the metabolite 
ratios in the anterior cingulate were not significantly correlated with the deficits in 












IPV vs Control 
subjects:P 
Stroop mean total 
score 
41.7 +/- 8.3  54.3 +/- 0.0 
          
 
0.001 
Stroop mean Word 
score 
 
96.3+/- 14.1 111.1 +/- 14.4 0.016 
Stroop mean 
Colour score 
71.8 +/- 9.7 88.9 +/- 12.5 0.001 
Trail Making Test 
Part B (time to 
complete) 
 
77.2 +/- 35.2 46.4 +/- 14.5 0.012 
 
The final study under review describes the neural correlates of PTSD related 
hyperarousal or anticipatory fear. Simmons et al hypothesize that women with IPV 
related PTSD relative to non-traumatized control (NC), show increased 
anterior/middle insula activation during anticipatory processing, and that exaggerated 
insula reactivity is functionally connected to increased amygdala activity during the 
anticipation of aversive stimuli [6]. Also, given that the insula is thought to play a key 
role in the hyperarousal component of PTSD, the authors hypothesize that the 
anterior/middle insula activity would relate more strongly to hyperarousal symptoms 













15 women with IPV-PTSD (3 subjects had sub-threshold PTSD) and 15 healthy 
controls completed a cued anticipation task (involving images of positive and 
negative events) during functional magnetic resonance imaging (fMRI). The 
diagnosis of PTSD was made using CAPS. No detail is given regarding the measure 
of IPV. Although 3 of the 15 women with IPV-PTSD, were sub-threshold for PTSD, 
their results were included in the final analyses as excluding them did not change the 
results in any meaningful way.  
 
Summary of results: Functional Activation and Neural Networks in Women with 
Posttraumatic Stress Disorder Related to Intimate Partner Violence [6] 
 
Behavioural 
There was no significant difference in response latency and accuracy between the 
IPV-PTSD and NC subjects during the task.  
 
Brain Activation 
Both groups of subjects had increased activation of bilateral anterior insula during 
anticipation of negative compared to positive stimuli. The IPV-PTSD subjects had 
greater activation in the right anterior/middle insula in anticipation of negative stimuli 
compared to the NC subjects. 
 
Functional Connectivity 
Functional connectivity between activation in bilateral anterior insula and bilateral 
amygdala and between right anterior/middle insula and bilateral amygdala were 














Brain Behaviour Relationships 
In the IPV-PTSD group there was a positive correlation between the IES-R 
Hyperarousal scores and activity in the left anterior insula. 
 
Taken together, these data suggest that in women with IPV-related PTSD: 1) the 
anterior and anterior/middle insula are important in cued anticipation of negative 
stimuli; 2) subregions of the insula, such as the anterior/middle insula, are 
hyperactivated during negative anticipation; and 3) anterior/middle insula activity 
might be most strongly related to symptoms of hyperarousal in IPV related PTSD. 
 
This literature review yielded 4 case-control studies with heterogeneous hypotheses 
and outcome measures in women with IPV. The overall quality of the studies was 
good. Details of how the subjects were selected were provided. All studies used valid 
and reliable questionnaires to measure IPV and other variables such as PTSD and 
depression. Most of the subjects were recruited from community centers that were 
involved with domestic violence. It is possible that women who seek help for IPV 
differ from women who fail to report IPV. This limits the generalisability of the 
findings.  
 
In summary, although the findings from the studies require replication, what they 
suggest is that women with IPV have a subtle pattern of cognitive impairment, with 
minor deficits seen in working memory, executive function and visuoconstruction. 
Structural brain changes are also reported in women with IPV. These differences  
include smaller supratentorial cranial vaults and smaller frontal and occipital grey 
matter volumes. Unlike in PTSD, neuronal integrity of the amygdala appears 
unaltered in women with IPV who display deficits in executive functioning. Taken 
together, these data suggest that IPV exposure is associated with dysfunction of 












hyperactivity of the insula in anticipation of negative events is strongly related to 
hyperarousal symptoms of PTSD.   
 
This review underscores the need for more research on the effects of violence 
against women. Although some work shows that women with IPV exposure have 
neurological deficits and structural brain changes, future longitudinal studies are 
required to determine causality of the neurobiological differences seen in women with 
and without IPV. Furthermore, integrated methodologies are needed to translate 
neuropsychological and neuroimaging results into the real world. The functional 
significance, for example, of executive functioning difficulties in victims of IPV may 
make individuals more susceptible to violence or influence their ability to leave a 
violent partner. In conclusion, refining our understanding of the pathways that lead to 
adverse health outcomes related to IPV creates opportunities for developing better 
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